Seite - (000270) - in Biomedical Chemistry: Current Trends and Developments

Sato, A. K.; Viswanathan, M.; Kent, R. B.; Wood, C. R. (2006). Therapeutic peptides: technological advances driving peptides into development. Current Opinion in Biotechnology, 17, 638-642. Selsted, M. E.; Harwig, S. S.; Ganz, T.; Schilling, J. W.; Lehrer, R. I. (1985). Primary structures of three human neutrophil defensins. Journal of Clinical Investigation, 76, 1436-1439. Shan, D.; Nicolaou, M. G.; Borchardt, R. T.; Wang, B. (1997). Prodrug strategies based on intramolecular cyclization reactions. Journal of Pharmaceutical Sciences, 86, 765-767. Shai, Y. (1999). Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by K-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochimica et Biophysica Acta, 1462, 55-70. Simmaco, M.; Mignogna, G.; Barra, D. (1999). Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers, 47, 435-450. Sinhababu, A. K.; Thakker, D. R. (1996). Prodrugs of anticancer agents. Advanced Drug Delivery Research, 19, 241-273. Smith, K. H.; Tejeda-Montes, E.; Poch, M.; Mata, A. (2011). Integrating top-down and self- assembly in the fabrication of peptide and protein-based biomedical materials. Chemical Society Reviews, 40, 4563-4577. Song, X.; Lorenzi, P. L.; Landowski, C. P.; Vig, B. S.; Hilfinger, J. M.; Amidon, G. L.; (2005). Amino acid ester prodrug of the anticancer agent Gemcitabine: synthesis, bioconversion, metabolic bioevasion and hPEPT1-mediated transport. Molecular Pharmaceutics, 2, 157-167. Soomets, U.; Lindgren, M.; Gallet, X.; Hällbrink, M.; Elmquist, A.; Balaspiri, L.; Zorko, M.; Pooga, M.; Brasseur, R.; Langel, Ü. (2000). Deletion analogues of transportan. Biochimica et Biophysica Acta, Biomembranes 1467, 165-176. Sorensen, O.; Cowland, J. B.; Askaa, T.; Borregaard, N. (1997). An elisa for hcap-18, the cathelicidin present in human neutrophils and plasma. Journal of Immunological Methods, 206, 53-59. Soul-Lawton, J.; Seaber, E.; On, N.; Wootton, R.; Rolan, P.; Posner, J. (1995). Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrobial Agents Chemotherapy, 39, 2759- 2764. Srinivasan, G.; James, C. M.; Krzycki J. A. (2002). Pyrrolysine encoded by UAG in Archaea: charging of a UAG-decoding specialized tRNA. Science, 296, 1459-1462. Stadtman T. C. (1996). Selenocysteine. Annual Review of Biochemistry, 65, 83-100. Stadtman, T. C. (2000). Selenium Biochemistry. Mammalian Selenoenzymes. Annals of the New York Academy of Sciences, 899, 399-402. Stephanopoulos, N.; Ortony, J. H.; Stupp, S. I. (2013). Self-assembly for the synthesis of functional biomaterials. Acta Materialia, 61, 912-930. Sugawara, M.; Huang, W.; Fei, Y. J.; Leibach, F. H.; Ganapathy, V.; Ganapathy, M. E. (2000). Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. Journal of Pharmaceutical Sciences, 89, 781-789. Tanaka, H.; Ishibashi, J.; Fujita, K.; Nakajima, Y.; Sagisaka, A.; Tomimoto, K.; Suzuki, N.; Yoshiyama, M.; Kaneko, Y.; Iwasaki, T.; Sunagawa, T.; Yamaji, K.; Asaoka, A.; Mita, K.; Yamakawa, M. (2008). A genome-wide analysis of genes and gene families involved in innate immunity of Bombyx mori. Insect Biochemistry and Molecular Biology, 38, 1087-1110.